Pediatric pulmonology · Rapid-Onset Obesity With Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome

Daily Management: Respiratory and Endocrine Care

At a Glance

Daily ROHHAD care centers on finding shallow breathing during sleep with regular sleep studies and carbon dioxide monitoring, using BiPAP when needed, replacing documented hormone deficiencies, protecting water and sodium balance, and supporting weight management.

Daily management for a child with ROHHAD involves a dedicated focus on two main areas: breathing and hormones. Because the condition changes over time, care is supportive—meaning doctors treat the symptoms as they appear ^[1]. This requires a proactive, “eyes-wide-open” approach to catch new challenges early.

Respiratory Care: Monitoring and Support

Breathing issues in ROHHAD are often “silent” because they occur primarily during sleep. Your child’s brain may not properly signal the lungs to breathe deeply enough, a process called hypoventilation ^[2].

Serial Sleep Studies: Regular polysomnography (PSG)—a complete sleep study—is crucial. Your specialist team determines the schedule (for example, every 3 to 6 months) depending on age, symptoms, prior CO2 results, illness, and current support ^[2]. It is vital that this study includes continuous CO2 monitoring (such as transcutaneous CO2), because a child’s CO2 can rise to dangerous levels before their oxygen levels drop ^[2]^[3].
Ventilation Support:
- Non-invasive Ventilation (BiPAP): Many children will need a BiPAP machine at night. Unlike a standard CPAP, a BiPAP (Bilevel Positive Airway Pressure) supports ventilation by providing two different pressures to help push air in and assist with breathing out ^[3]^[4].
- Tracheostomy: If BiPAP is not enough to keep CO2 levels safe, or if a child begins to hypoventilate while awake, the team may determine that a different mode or a tracheostomy (a surgical opening in the neck for a breathing tube) is indicated ^[5]^[6].

Endocrine Care: Balancing the System

Because the hypothalamus is not functioning correctly, your child’s body may not produce the hormones needed to regulate growth, energy, and water balance ^[1]. Management involves hormone replacement therapy to mimic what the body should be doing naturally. These treatments are only for children with documented deficiencies; never start, stop, or change doses without consulting your prescribing team.

Thyroid: Levothyroxine is often prescribed for central hypothyroidism ^[7].
Adrenal Function: If the child is diagnosed with central adrenal insufficiency, hydrocortisone will be needed. This requires a clinician-written plan specifying the diagnosis, dose, and sick-day/emergency rules for “stress doses” during illness ^[7]^[8].
Water Balance: Children with documented central diabetes insipidus or adipsia (a lack of thirst) may need DDAVP (Desmopressin) and a strict, individualized fluid schedule. Without a clinician-written plan for monitoring, DDAVP or a fixed fluid prescription can cause dangerous sodium imbalances (hypernatremia or hyponatremia) ^[9]^[10].
Growth: Growth hormone therapy may be used if testing shows a deficiency ^[1]^[11].

The Challenge of ROHHAD Obesity

The obesity in ROHHAD is distinct from typical childhood weight gain. It is hypothalamic obesity, meaning the brain’s signals for hunger (hyperphagia) and fullness are disrupted ^[12]^[13].

Because this weight gain is driven by the brain rather than just calories, it is notoriously resistant to standard diet and exercise ^[13]. While a healthy lifestyle is still encouraged to support overall heart and bone health, the focus is often on preventing further rapid gain through a highly structured environment and multidisciplinary behavioral support ^[14]^[15]. Some newer medications, like GLP-1 agonists, are being studied, but they are not yet a standard treatment for all children with ROHHAD ^[16]^[11].

Common questions in this guide

What is the purpose of carbon dioxide monitoring during my child’s sleep study?

In ROHHAD, breathing can become too shallow mainly during sleep, and carbon dioxide can rise before oxygen levels fall. Continuous carbon dioxide monitoring during a sleep study helps the care team detect this problem and decide when testing or breathing support should be adjusted.

How is BiPAP different from CPAP for a child with ROHHAD?

BiPAP provides separate pressure levels for breathing in and breathing out, which can help support ventilation. Standard CPAP provides one continuous pressure and may not provide the same assistance, so the respiratory and sleep team chooses the appropriate support for each child.

When might a child with ROHHAD need a tracheostomy?

A tracheostomy may be considered when BiPAP or another non-invasive approach cannot keep carbon dioxide at a safe level, or when hypoventilation occurs while the child is awake. It is a surgical opening in the neck for a breathing tube and requires an individualized decision by the child’s specialist team.

What hormone treatments might a child with ROHHAD need?

Treatment depends on documented deficiencies: levothyroxine may be used for central hypothyroidism, hydrocortisone for central adrenal insufficiency, DDAVP for central diabetes insipidus or adipsia, and growth hormone for a confirmed deficiency. A child taking hydrocortisone needs a written illness and emergency stress-dose plan, and doses should not be changed without the prescribing team.

How can families prevent dangerous sodium changes when using DDAVP or a fluid plan?

Children with central diabetes insipidus or adipsia may need DDAVP and an individualized schedule for fluids and sodium monitoring. DDAVP or a fixed fluid prescription without a clinician-written plan can make sodium too high or too low, so families should follow the plan provided by the treating team.

Why is weight gain difficult to control in ROHHAD?

ROHHAD-related hypothalamic obesity results from disrupted hunger and fullness signals, so it is not simply a matter of eating too much or exercising too little. Healthy habits support heart and bone health, but structured routines and multidisciplinary behavioral support are often needed; GLP-1 medicines are still being studied and are not standard for every child.

What changes could mean my child’s nighttime breathing needs to be reassessed?

Increasing daytime sleepiness, morning headaches, or unusual irritability can be signs that nighttime breathing is not adequately supported. Share these changes with the care team promptly, along with any problems using the BiPAP mask, and do not change ventilator settings without clinical guidance.

Get notified when new evidence is published on Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

Regular sleep studies with continuous carbon dioxide monitoring help identify silent nighttime hypoventilation and guide breathing support.
BiPAP is commonly used at night, but another ventilation method or a tracheostomy may be needed if carbon dioxide remains unsafe or hypoventilation occurs while awake.
Levothyroxine, hydrocortisone, DDAVP, and growth hormone should be used only for documented deficiencies under an individualized prescribing-team plan.
Children with adrenal insufficiency, diabetes insipidus, or adipsia need written illness, stress-dose, fluid, and sodium-monitoring instructions to reduce the risk of dangerous imbalances.
ROHHAD-related hypothalamic obesity is often resistant to standard diet and exercise, making structured routines and multidisciplinary support important while GLP-1 medicines remain under study.

References (16)

1
Clinical Description of Ten Pediatric Patients with Clinical Signs of ROHHAD-NET Syndrome and Review of the Literature.
Aziz M, Leske V, Guerdile MJ, et al.
Hormone research in paediatrics 2025; 1-11 doi:10.1159/000549050.
PMID: 41118323
2
Case Report: Considerations of nocturnal ventilator support in ROHHAD syndrome in chronic care of childhood central hypoventilation with hypothalamus dysfunction.
Zhao R, Dong X, Gao Z, Han F
Frontiers in pediatrics 2022; (10()):919921 doi:10.3389/fped.2022.919921.
PMID: 36120657
3
ROHHAD syndrome and evolution of sleep disordered breathing.
Reppucci D, Hamilton J, Yeh EA, et al.
Orphanet journal of rare diseases 2016; (11(1)):106 doi:10.1186/s13023-016-0484-1.
PMID: 27473663
4
Images: Sleep-disordered breathing and hypoventilation in a child with obesity and hypothalamic dysfunction.
Ghosh R, Malik M, Daley TC, Kasi AS
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2022; (18(1)):339-342 doi:10.5664/jcsm.9636.
PMID: 34534067
5
Rapid-onset obesity with hypothalamic dysregulation, hypoventilation, and autonomic dysregulation (ROHHAD syndrome): A case report and literature review.
Ibáñez-Micó S, Marcos Oltra AM, de Murcia Lemauviel S, et al.
Neurologia (Barcelona, Spain) 2017; (32(9)):616-622 doi:10.1016/j.nrl.2016.04.008.
PMID: 27340018
6
The Perfect Storm: A Case of Rapid-Onset Obesity With Hypoventilation, Hypothalamic, Autonomic Dysregulation, Neuroendocrine Tumor (ROHHADNET) With Heart Failure, Narcolepsy, and a Rare Location of a Pelvic Neuroendocrine Tumor.
Roby P, Smith Beltran G, Finch C, et al.
Cureus 2023; (15(12)):e50341 doi:10.7759/cureus.50341.
PMID: 38205461
7
Epidemiology of acquired hypothalamic obesity following traumatic brain injury and nonspecific hypothalamic microinjury: A nationwide German claims data analysis.
Witte J, Touchot N, Batram M, et al.
Journal of neuroendocrinology 2026; (38(1)):e70108 doi:10.1111/jne.70108.
PMID: 41236025
8
ROHHAD-NET Syndrome: A Case Series.
Soodhana D, Iyer MS, George J, et al.
Journal of the ASEAN Federation of Endocrine Societies 2025; (40(1)):126-132 doi:10.15605/jafes.040.01.10.
PMID: 40416472
9
Adipsic arginine vasopressin deficiency: challenges in managing the intricate interplay of adipsia with polyuria.
Malik A, Singh R, Goyal A, Gupta R
BMJ case reports 2024; (17(10)) doi:10.1136/bcr-2024-261497.
PMID: 39477460
10
Daily Sodium Monitoring and Fluid Intake Protocol: Preventing Recurrent Hospitalization in Adipsic Diabetes Insipidus.
Pabich S, Flynn M, Pelley E
Journal of the Endocrine Society 2019; (3(5)):882-886 doi:10.1210/js.2018-00406.
PMID: 31008421
11
Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time.
Jalal Eldin AW, Tombayoglu D, Butz L, et al.
Clinical diabetes and endocrinology 2019; (5()):9 doi:10.1186/s40842-019-0082-y.
PMID: 31333877
12
Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose Cyclophosphamide.
Jacobson LA, Rane S, McReynolds LJ, et al.
Pediatrics 2016; (138(1)).
PMID: 27313069
13
The Central Control of Energy Metabolism: Hypothalamic Obesity Is Not One Disease.
van Santen HM
Hormone research in paediatrics 2026; (99(2)):175-184 doi:10.1159/000543544.
PMID: 39819748
14
Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: A systematic review.
Van Roessel IMAA, Van Den Brink M, Dekker J, et al.
Clinical nutrition (Edinburgh, Scotland) 2024; (43(8)):1798-1811 doi:10.1016/j.clnu.2024.05.028.
PMID: 38955055
15
ROHHAD NET in Retrospect: Key Lessons Learned from Five Cases.
Priyadarshini S, Verma A, Paul PG, et al.
Indian journal of pediatrics 2025; (92(11)):1194-1200 doi:10.1007/s12098-024-05291-y.
PMID: 39722101
16
Melanocortin-4 Receptor Agonist Treatment of Hypothalamic Obesity in ROHHAD Syndrome.
Grünewald A, Steidel E, Müntjes C, et al.
Pediatrics 2026; (157(6)) doi:10.1542/peds.2025-074432.
PMID: 42114845

This page explains daily respiratory and endocrine care for a child with ROHHAD for informational purposes only and does not replace medical advice. Follow the individualized plans provided by your child’s respiratory, sleep, and endocrine teams.

Guide Contents